MGMT and glioblastoma: Unfortunately, therapeutic resistance and molecular heterogeneity contribute to the recurring nature of GBM, with nearly ubiquitous TMZ resistance attributed to the induction of the DNA repair enzyme O(6)-methylguanine-DNA methyltransferase, encoded by the MGMT gene [2–4].